Rafferty Asset Management, LLC Biogen Inc. Transaction History

Rafferty Asset Management, LLC

$26.8 Billion
Q2 2024

A detailed history of Rafferty Asset Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 151,295 shares of BIIB stock, worth $29.4 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

151,295

Previous 112,816 34.11%

Holding current value

$29.4 Million

Previous $24.3 Million 44.18%

% of portfolio

0.13%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $7.33 Million - $9.11 Million	38,479 Added 34.11%	151,295 $35.1 Million
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $3.59 Million - $4.53 Million	16,934 Added 17.66%	112,816 $24.3 Million
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $2.97 Million - $3.57 Million	13,335 Added 16.15%	95,882 $24.8 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $4.5 Million - $5.08 Million	17,754 Added 27.4%	82,547 $21.2 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $1.55 Million - $1.79 Million	5,628 Added 9.51%	64,793 $18.5 Million
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $716,828 - $816,797	2,794 Added 4.96%	59,165 $16.4 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $4.15 Million - $5.05 Million	-16,459 Reduced 22.6%	56,371 $15.6 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $3.48 Million - $4.8 Million	17,895 Added 32.57%	72,830 $19.4 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $1.56 Million - $1.85 Million	-8,299 Reduced 13.12%	54,935 $11.2 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $3.54 Million - $4.46 Million	18,274 Added 40.65%	63,234 $13.3 Million
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $3.54 Million - $4.54 Million	15,793 Added 54.15%	44,960 $10.8 Million
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $2.75 Million - $3.59 Million	9,718 Added 49.97%	29,167 $8.25 Million
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $2.5 Million - $4 Million	-9,647 Reduced 33.16%	19,449 $6.74 Million
Q1 2021 May 10, 2021	BUY	$242.95 - $284.63 $1.79 Million - $2.09 Million	7,355 Added 33.83%	29,096 $8.14 Million
Q4 2020 Feb 10, 2021	BUY	$236.26 - $355.63 $202,474 - $304,774	857 Added 4.1%	21,741 $5.32 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $745,327 - $860,573	2,815 Added 15.58%	20,884 $5.92 Million
Q2 2020 Aug 07, 2020	BUY	$258.66 - $342.55 $1.77 Million - $2.35 Million	6,856 Added 61.14%	18,069 $4.83 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $3.99 Million - $5.06 Million	-14,833 Reduced 56.95%	11,213 $3.55 Million
Q4 2019 Feb 10, 2020	SELL	$220.06 - $304.07 $2.34 Million - $3.23 Million	-10,611 Reduced 28.95%	26,046 $7.73 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $747,776 - $838,703	-3,439 Reduced 8.58%	36,657 $8.53 Million
Q2 2019 Aug 09, 2019	BUY	$219.29 - $241.72 $2.46 Million - $2.72 Million	11,237 Added 38.94%	40,096 $9.38 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $5.05 Million - $7.89 Million	23,281 Added 417.37%	28,859 $6.82 Million
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $136,743 - $173,200	-491 Reduced 8.09%	5,578 $1.68 Million
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $2.52 Million - $3.3 Million	-8,598 Reduced 58.62%	6,069 $2.14 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $1.48 Million - $1.77 Million	5,752 Added 64.52%	14,667 $4.26 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $1.14 Million - $1.61 Million	4,383 Added 96.71%	8,915 $2.44 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $103,059 - $115,434	-335 Reduced 6.88%	4,532 $1.44 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $1.37 Million - $1.6 Million	4,867	4,867 $1.52 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Biogen Inc. Transaction History